Amplyx Pharmaceuticals, Inc. -
Product Pipeline Review - 2014
Summary
Global
Markets Direct's, 'Amplyx Pharmaceuticals, Inc. - Product Pipeline Review -
2014', provides an overview of the Amplyx Pharmaceuticals, Inc.'s
pharmaceutical research and development focus.
This
report provides comprehensive information on the current therapeutic
developmental pipeline of Amplyx Pharmaceuticals, Inc.'s, complete with
comparative analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule type. It
also reviews latest updates, and featured news and press releases, along with
special features on late-stage and discontinued projects.
Click For Report Details @ http://www.radiantinsights.com/research/amplyx-pharmaceuticals-inc-product-pipeline-review-2014
Global
Markets Direct's report features investigational drugs from across globe
covering over 20 therapy areas and nearly 3,000 indications. The report is
built using data and information sourced from Global Markets Direct's
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct's
team. Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the profiles are
updated with the latest set of information. Additionally, processes including
live news & deals tracking, browser based alert-box and clinical trials
registries tracking ensure that the most recent developments are captured on a
real time basis.
The
report enhances decision making capabilities and help to create effective
counter strategies to gain competitive advantage. It strengthens R&D
pipelines by identifying new targets and MOAs to produce first-in-class and
best-in-class products.
Note*:
Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
-
The report provides brief overview of Amplyx Pharmaceuticals, Inc. including
business description, key information and facts, and its locations and
subsidiaries
-
The report reviews current pipeline of Amplyx Pharmaceuticals, Inc.'s human
therapeutic division and enlists all their major and minor projects
-
The report features product description and descriptive mechanism of action for
key pipeline products along with the product's developmental history and major
milestones
-
Special feature on out-licensed and partnered product portfolio
Reasons to buy
-
Evaluate Amplyx Pharmaceuticals, Inc.'s strategic position with total access to
detailed information on its product pipeline
-
Assess the growth potential of Amplyx Pharmaceuticals, Inc. in its therapy
areas of focus
-
Identify new drug targets and therapeutic classes in the Amplyx
Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives
to reinforce pipeline in those areas
-
Exploit in-licensing opportunities by identifying windows of opportunity to
fill portfolio gaps
About Radiant Insights
Radiant
Insights is a platform for companies looking to meet their market research and
business intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For more information visit, Radiant Insights
Contact Details:
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
Phone:
1-415-349-0054
Toll
Free: 1-888-202-9519
No comments:
Post a Comment